跳至主要内容
临床试验/CTRI/2020/01/022968
CTRI/2020/01/022968尚未招募2 期

An observational study to evaluate Neoadjuvant Rectal(NAR) score in rectal cancer.

Kastruba Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients of Rectal Cancer that require Neoadjuvant Chemotherapy
  • T3/T4 Tumours
  • T1/T2 with node involvement
  • Mesorectal Fascia involvement
  • 2.Perfomance score 0-2 ECOG
  • 3.Provides a voluntry informed consent to participate in the study

排除标准

  • 1.Metastatic disease at presentation.
  • 2. history of radiotherapy for rectal cancers or other cancers of the pelvic region.
  • 3.Patients receiving short course RT.
  • 4.Relative contraindications to pelvic radiotherapy like presence of connective tissue disorders or irritable bowel syndrome/inflammatory bowel disease.
  • 5. Patients not having adequate pre radiotherapy staging assessment like MRI.
  • 6. Unfit or contraindicated to receive concurrent systemic chemotherapy due to presence of comorbidities, known allergy, etc.

研究者

发起方
Kastruba Medical College

相似试验